Results 81 to 90 of about 1,536 (210)

Nephrogenic systemic fibrosis associated with stromal and vascular calcification, report of two cases [PDF]

open access: yes, 2009
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/75035/1/j.1600-0560.2008.01205.x ...
Alegre, Maria-Luisa   +10 more
core   +1 more source

Scleromyxedema

open access: yesRheumatology, 2021
Chao-Han Liu, Yen-Yun Tsai, Ya-Chih Tien
openaire   +2 more sources

High-Dose Intravenous Immunoglobulin in Skin Autoimmune Disease

open access: yesFrontiers in Immunology, 2019
The immunomodulatory potential and low incidence of severe side effects of high-dose intravenous immunoglobulin (IVIg) treatment led to its successful application in a variety of dermatological autoimmune diseases over the last two decades.
Jochen H. O. Hoffmann, Alexander H. Enk
doaj   +1 more source

Biomarkers in skin autoimmunity—An update on localised scleroderma

open access: yesSkin Health and Disease, Volume 4, Issue 2, April 2024.
Newest research on biomarkers in localised scleroderma reviewed. Abstract Human autoimmune diseases are complex and highly diverse conditions that can be of localised or systemic nature. Understanding the basic biology of autoimmune diseases goes hand in hand with providing the clinics with valuable biomarkers for managing these diseases.
Adrián Hernández‐Bustos   +2 more
wiley   +1 more source

Reticular erythematous mucinosis: A rare cutaneous mucinosis [PDF]

open access: yes, 2019
Reticular erythematous mucinosis (REM) is a rare form of primary cutaneous mucinosis, most often involving the midline of the upper chest or back in middle-aged women. REM bears clinical and histopathologic resemblance to lupus erythematosus tumidus (LET)
Amer Ali Almohssen   +2 more
core   +1 more source

Scleroderma mimics – Clinical features and management [PDF]

open access: yes, 2020
Systemic sclerosis is a severe immune-mediated rheumatic disease by virtue of its clinical impact and mortality. There are a number of other sclerosing skin diseases that should be considered in the differential diagnosis and these are important because ...
Denton, CP, Ong, VH, Orteu, CH
core  

Scleromyxedema with systemic involvement mimics rheumatic diseases [PDF]

open access: yes, 1986
Scleromyxedema is an infiltrative skin disease produced by hyaluronic acid deposition in the dermis. A benign monoclonal gammopathy is usually present. We report 2 patients with scleromyxedema and systemic illnesses.
Chanda   +14 more
core   +1 more source

Discrete papular lichen myxedematosus: a rare entity or an under- diagnosed disease? [PDF]

open access: yes, 2016
Primary cutaneous mucinoses are characterized by abnormal mucin deposits in the skin. Discrete papular lichenmyxedematosus (DPLM) is an unusual subtype which is characterized by the presence of multiples  smooth, waxy, or flesh-colored papules, 2 to 5 mm
Gallouj, Salim   +3 more
core   +1 more source

Scleromyxedema (Arndt - Gottron Syndrome) Developing Under Tenofovir Treatment for Hepatitis B: Unique Presentation in a Bulgarian Patient! [PDF]

open access: yes, 2019
BACKGROUND: Scleromyxedema, also referred to as the Arndt-Gottron (S-AG) syndrome or the systemic form of Lichen myxedematosus (LM), is a cutaneous mucinosis with a chronic course and high lethality from systemic involvement of other organs and systems ...
Patterson, James   +2 more
core   +3 more sources

Home - About - Disclaimer - Privacy